Clinical Trial Update: Treatment With UX007 for a Single Patient With GLUT1 Deficiency Syndrome

View source ↗

Summary

The document reports a clinical trial update where UX007 (triheptanoin) was used to treat a single patient with Glucose transporter type 1 deficiency syndrome; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucose Transporter Type Deficiency Syndrome

Drugs mentioned

• UX007 (triheptanoin)

Snippet

Sponsor: Jerry Vockley, MD, PhD | Conditions: Glucose Transporter 1 Deficiency Syndrome | Status: NO_LONGER_AVAILABLE